Parker v. Berryhill

CourtDistrict Court, D. Minnesota
DecidedSeptember 4, 2018
Docket0:17-cv-03844
StatusUnknown

This text of Parker v. Berryhill (Parker v. Berryhill) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Parker v. Berryhill, (mnd 2018).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA

Ebony Parker, Case No. 17-cv-3844 (SER)

Plaintiff, ORDER v.

Nancy A. Berryhill, Acting Commissioner of Social Security,

Defendant.

STEVEN E. RAU, United States Magistrate Judge Pursuant to 42 U.S.C. § 405(g), Plaintiff Ebony Parker (“Parker”) seeks review of the Acting Commissioner of Social Security’s (the “Commissioner”) denial of her application for supplemental security income (“SSI”). See (Compl. for Judicial Review of Decision of the Comm’r of Soc. Sec., “Compl.”) [Doc. No. 1]; (Admin. R.) [Doc. Nos. 13–20 at 291]. The parties filed cross-motions for summary judgment. (Pl.’s Mot. for Summ. J.) [Doc. No. 21]; (Def.’s Mot. for Summ. J.) [Doc. No. 23]. For the reasons set forth below, the Court denies Parker’s Motion for Summary Judgment and grants the Commissioner’s Motion for Summary Judgment. I. BACKGROUND A. Procedural History Parker filed for DIB on July 1, 2013, citing an alleged onset date (“AOD”) of October 1, 2012. (Admin. R. at 291). Parker’s application identified disabilities due to lupus. (Id. at 314). Parker’s claims were denied initially and upon reconsideration. (Id. at 146, 159). Following three hearings and the submission of supplemental records, the administrative law judge (the “ALJ”) denied benefits to Parker on June 16, 2016. (Id. at 11–32). The Appeals Council denied Parker’s request for review, rendering the ALJ’s decision final. (Id. at 1); see 20 C.F.R. § 416.1481. Parker initiated the instant lawsuit on August 21, 2017. (Compl.). Parker makes three arguments: (1) the ALJ ignored four factors that explain Parker’s non-

compliance with treatment; (2) the ALJ “cherry-picked” evidence evaluating Parker’s credibility; and (3) the testifying medical experts did not address conflicting evidence in the record. See (Mem. in Supp. of Pl.’s Mot. for Summ. J., “Parker’s Mem. in Supp.”) [Doc. No. 22 at 37–44]. B. Factual Background The majority of the Administrative Record, which spans more than 8,000 pages, consists of medical records of Parker’s numerous emergency room visits, hospital stays, and clinic appointments related to her diagnosis of systemic lupus erythematosus (“SLE” or “lupus”) and associated symptoms and complications. See, e.g., (Admin. R. at 429). SLE is “an inflammatory connective tissue disease with variable features.” Systemic lupus erythematosus 515390, Stedman’s Medical Dictionary, Westlaw (database updated Nov. 2014). The Court reviewed the

entire Administrative Record, but summarizes only the testimony of Parker and the relevant medical experts when appropriate. The records are discussed in more detail in the analysis of this Order. 1. Parker’s Background and Testimony On her AOD, Parker was eighteen years old, making her a younger individual. See (Admin. R. at 291); 20 C.F.R. § 416.963(c). Parker has never worked and did not graduate from high school. (Admin. R. at 81, 96). She receives medical assistance and food support through the county. (Id. at 96). She testified lupus causes fevers, joint pain, kidney problems, and frequent hospitalizations. (Id. at 97). During these hospitalizations, she is treated with steroids and painkillers most often. (Id. at 100). About half of the time, she is treated with antibiotics. (Id.). Initially, Parker testified in July 2015 that she was taking prednisone1 and Plaquenil2 as directed. (Id. at 102). Sometimes she forgets to take her medicine, but she gets sick regardless. (Id. at 117); see also (id. at 61). In April 2016, she testified

that she stopped taking Plaquenil because it made her vision blurry. (Id. at 61). She also testified that she stopped taking all her medication, including prednisone, in November 2015 because she was depressed and did not want to take it anymore. (Id. at 62); see also (id. at 63). She testified that she knows that she is supposed to take her medicine to prevent flares, but the medicine does not always help. (Id. at 62–64). On days when Parker is not hospitalized, she is able to go for walks, care for herself, and cook. (Id. at 104); see also (id. at 322) (function report); but see (id. at 339) (another function report stating she does not cook). She said she has memory problems. (Id. at 103, 117). Parker testified that she stopped drinking in October 2015, but before that she “drank all the time,” meaning almost every day. (Id. at 119, 125). She took the bus to various liquor stores,

where her friends or family members would buy alcohol for her. (Id. at 122–23). She smokes marijuana every day. (Id. at 65). 2. Dr. Steiner’s Testimony Andrew Steiner, MD (“Dr. Steiner”), testified at the third hearing before the ALJ on April 20, 2016. See (Admin. R. at 56–57, 68). He testified that Parker’s impairments did not satisfy

1 Prednisone is a corticosteroid that works on the immune system to relieve inflamed areas of the body. Prednisone (Oral Route), Mayo Clinic, https://www.mayoclinic.org/drugs- supplements/prednisone-oral-route/description/drg-20075269 (last updated Mar. 1, 2017). 2 Plaquenil is the brand name of hydroxychloroquine, which is used to help control lupus symptoms. Hydroxychloroquine (Oral Route), Mayo Clinic, https://www.mayoclinic.org/drugs- supplements/hydroxychloroquine-oral-route/description/drg-20064216 (last updated Mar. 1, 2017). Listing 14.02 (systemic lupus erythematosus). See (id. at 70–71). He noted that the record contained “repeated reference to non-compliance” in the form of “either missing appointments or not taking medicines as prescribed.” (Id. at 70). More specifically, he said that “we don’t know what [Parker would] be like if she took her medication on a regular basis, and followed her doctors’

advice in regards to managing her condition.” (Id. at 73). Dr. Steiner testified that a sedentary job that did not include lifting, time on feet, environments with high concentrations of pollutants would be appropriate, and testified that he did not know if Parker could be restored to such a condition that she would be able to work. (Id. at 71, 73). 3. Dr. Lace’s Testimony Michael Lace, PsyD (“Dr. Lace”), also testified at the April 20, 2016 hearing. (Admin. R. at 56–57). He said Parker’s activities of daily living are moderately restricted, she has marked difficulties in maintaining social function, and marked difficulties in maintaining concentration, persistence, or pace. (Id. at 77–78). If Parked stopped her substance use, Dr. Lace testified she would have mildly restricted activities of daily living, moderate difficulties in maintaining social

functioning, and moderate difficulties in maintaining concentration, persistence, or pace. (Id. at 78). Dr. Lace testified that Parker should be “limited to simple, routine, repetitive types of tasks” and demands that are “no greater than very brief, very superficial contact with all groups, co- workers, the general public, as well as supervisors.” (Id. at 79). Additionally, Parker should be limited to “a work setting where there’s no access to or contact with prescription medications, alcohol, or illegal drugs.” (Id.). C. The ALJ’s Decision Consistent with the Social Security Administration’s regulations, the ALJ conducted the five-step eligibility analysis. (Admin. R. at 11–32); see 20 C.F.R. § 416.920(a)(4). The ALJ found that Parker had the following severe impairments:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Parker v. Berryhill, Counsel Stack Legal Research, https://law.counselstack.com/opinion/parker-v-berryhill-mnd-2018.